DOCHERTY JOHN MARTIN 4
4 · Lexaria Bioscience Corp. · Filed Aug 29, 2022
Insider Transaction Report
Form 4
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
- Award
Stock Options
2022-08-29+30,000→ 94,668 totalExercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying)
Holdings
- 54,075(indirect: Private Holding Company)
common shares
- 49,668
Stock Options
Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (18,334 underlying) - 31,334
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (18,000 underlying) - 13,334
Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (13,334 underlying) - 64,668
Stock Options
Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying)